gvtcx

NP47822 Multiple Sclerosis Medicines

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£17,031,052
Statuscomplete
Category (CPV) 33600000
RegionScotland
Deadline1 Dec 2022
Procedureopen
OCIDocds-h6vhtk-037dca

Awards (4)

This procurement was awarded to 4 suppliers. Values shown are per-award; the notice total is £17,031,052.

SupplierValueDateStatus
Biogen Idec Ltd shared · · active
Merck Serono Limited shared · · active
Mylan shared · · active
Teva UK Limited shared · · active

description

Supply of Multiple Sclerosis Medicines to NHS Scotland

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
31 Oct 2022 Contract notice (F02) Earlier regulations 030719-2022
15 Feb 2023 Contract award notice (F03) Earlier regulations 004666-2023

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.